#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15940	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2435	805.1	0	.	n	.	0	C1450T	SNP	1450	1450	C	1851	1851	T	1030	T,A,C,G	1025,3,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15940	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2435	805.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1585	1585	C	1025	C,T	1024,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15940	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2435	805.1	0	HET	.	.	.	A69G	.	69	69	A	470	470	A	1001	A,G	568,432	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27192	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4171	812.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1981	1981	A	1160	A,C	1159,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27192	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4171	812.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2615	2615	C	897	C,A	896,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27192	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4171	812.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2689	2689	A	858	A,T	856,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27192	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4171	812.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	3241	3241	C	1003	C,T,A	999,2,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_U_01433c	folP.WHO_U_01433c	1	1	539	2268	folP	852	852	99.88	folP.l15.c4.ctg.1	1978	142.9	0	.	p	.	0	E151K	NONSYN	451	453	GAA	987	989	AAA	237;235;233	A,C;A;A	236,1;235;233	.	.
folP.WHO_U_01433c	folP.WHO_U_01433c	1	1	539	2268	folP	852	852	99.88	folP.l15.c4.ctg.1	1978	142.9	1	SNP	p	R228S	1	.	.	682	684	AGC	1218	1220	AGC	227;227;227	A,C;G;C	226,1;227;227	folP.WHO_U_01433c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5258	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3748	174.8	1	SNP	p	S91F	0	.	.	271	273	TCC	725	727	TCC	190;188;189	T;C,G,A;C	190;186,1,1;189	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5258	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3748	174.8	1	SNP	p	D95G	0	.	.	283	285	GAC	737	739	GAC	205;205;202	G;A,T,C;C	205;203,1,1;202	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5258	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3748	174.8	1	SNP	p	D95N	0	.	.	283	285	GAC	737	739	GAC	205;205;202	G;A,T,C;C	205;203,1,1;202	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	2100	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1785	146.2	1	SNP	p	G45D	0	.	.	133	135	GGC	665	667	GGC	240;241;242	G;G,A;C	240;240,1;242	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1220	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1408	108.2	0	.	n	.	0	A197.	DEL	197	197	A	815	815	A	227	A	227	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5200	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3429	189.0	1	SNP	p	D86N	0	.	.	256	258	GAC	831	833	GAC	250;249;249	G,A;A;C	248,2;249;249	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5200	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3429	189.0	1	SNP	p	S87W	0	.	.	259	261	AGT	834	836	AGT	246;247;247	A,C;G;T	245,1;247;247	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5200	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3429	189.0	1	SNP	p	S87I	0	.	.	259	261	AGT	834	836	AGT	246;247;247	A,C;G;T	245,1;247;247	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5200	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3429	189.0	1	SNP	p	S87R	0	.	.	259	261	AGT	834	836	AGT	246;247;247	A,C;G;T	245,1;247;247	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5200	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3429	189.0	1	SNP	p	S88P	0	.	.	262	264	TCC	837	839	TCC	249;250;252	T;C;C,A,G	249;250;249,2,1	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4834	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3114	193.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1750	1752	GGC	259;253;250	G;G;C,T	259;253;249,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	4450	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2820	196.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1500	1502	GCA	268;267;266	G;C,G;A	268;265,1;266	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4450	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2820	196.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1503	1505	ATC	266;267;266	A;T,C;C	266;266,1;266	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4450	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2820	196.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1515	1517	GTG	265;266;268	G;T,A;G	265;265,1;268	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4450	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2820	196.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1515	1517	GTG	265;266;268	G;T,A;G	265;265,1;268	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4450	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2820	196.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2019	2021	ACC	257;257;252	A;C,A;C	257;256,1;252	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4450	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2820	196.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2073	2075	GCG	249;247;246	G;C,G;G	249;246,1;246	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4450	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2820	196.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2073	2075	GCG	249;247;246	G;C,G;G	249;246,1;246	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4450	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2820	196.9	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2196	2198	GGC	249;252;253	G;G;C	249;252;253	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4450	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2820	196.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2205	2207	GGC	265;264;260	G;G;C	265;264;260	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4450	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2820	196.9	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2223	2225	CTG	264;265;266	C;T;G	264;265;266	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5876	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3637	201.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1844	1846	CCG	233;234;232	C;C;G	233;234;232	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2726	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2327	146.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	867	867	C	212	C	212	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	338	porB1a	984	227	90.31	porB1a.l6.c30.ctg.2	495	23.8	0	.	p	.	0	V258L	NONSYN	772	774	GTA	133	135	TTA	24;28;30	T;T;A	24;28;30	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	338	porB1a	984	227	90.31	porB1a.l6.c30.ctg.2	495	23.8	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	178	180	CAT	65;65;65	C;A;T	65;65;65	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	338	porB1a	984	227	90.31	porB1a.l6.c30.ctg.2	495	23.8	0	.	p	.	0	D274S	NONSYN	820	822	GAT	181	183	AGT	65;65;65	A;G;T	65;65;65	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	338	porB1a	984	227	90.31	porB1a.l6.c30.ctg.2	495	23.8	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	190	192	TAC	65;65;65	T;A;C	65;65;65	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	338	porB1a	984	227	90.31	porB1a.l6.c30.ctg.2	495	23.8	0	.	p	.	0	R307A	NONSYN	919	921	AGA	280	282	GCA	1;1;1	G;C;A	1;1;1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	338	porB1a	984	227	90.31	porB1a.l6.c30.ctg.2	495	23.8	0	.	p	.	0	T311A	NONSYN	931	933	ACA	292	294	GCA	1;1;1	G;C;A	1;1;1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	338	porB1a	984	227	90.31	porB1a.l6.c30.ctg.2	495	23.8	0	.	p	.	0	E312D	NONSYN	934	936	GAA	295	297	GAC	1;1;1	G;A;C	1;1;1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	338	porB1a	984	227	90.31	porB1a.l6.c30.ctg.2	495	23.8	0	.	p	.	0	F314I	NONSYN	940	942	TTC	301	303	ATC	1;1;1	A;T;C	1;1;1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	338	porB1a	984	227	90.31	porB1a.l6.c30.ctg.2	495	23.8	0	.	p	.	0	A316S	NONSYN	946	948	GCG	307	309	TCG	1;1;1	T;C;G	1;1;1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	338	porB1a	984	227	90.31	porB1a.l6.c30.ctg.2	495	23.8	0	.	p	.	0	V318A	NONSYN	952	954	GTC	313	315	GCC	1;1;1	G;C;C	1;1;1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	338	porB1a	984	227	90.31	porB1a.l6.c30.ctg.2	495	23.8	0	.	p	.	0	G319S	NONSYN	955	957	GGC	316	318	AGC	1;1;1	A;G;C	1;1;1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	338	porB1a	984	227	90.31	porB1a.l6.c30.ctg.2	495	23.8	0	.	p	.	0	G320A	NONSYN	958	960	GGT	319	321	GCC	1;1;1	G;C;C	1;1;1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	338	porB1a	984	227	90.31	porB1a.l6.c30.ctg.2	495	23.8	0	.	p	.	0	G322V	NONSYN	964	966	GGT	325	327	GTT	1;1;1	G;T;T	1;1;1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3316	porB1b	1047	1047	99.14	porB1b.l6.c30.ctg.1	1981	208.1	0	.	p	.	0	N38E	NONSYN	112	114	AAT	663	665	GAA	310;312;311	G;A;A,G	310;312;310,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3316	porB1b	1047	1047	99.14	porB1b.l6.c30.ctg.1	1981	208.1	0	.	p	.	0	N134D	NONSYN	400	402	AAT	951	953	GAT	279;279;279	G;A;T,G	279;279;278,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3316	porB1b	1047	1047	99.14	porB1b.l6.c30.ctg.1	1981	208.1	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1074	1076	TCA	295;297;298	T;C,A;A	295;296,1;298	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3316	porB1b	1047	1047	99.14	porB1b.l6.c30.ctg.1	1981	208.1	0	.	p	.	0	Y216H	NONSYN	646	648	TAT	1197	1199	CAT	281;283;281	C;A;T	281;283;281	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3316	porB1b	1047	1047	99.14	porB1b.l6.c30.ctg.1	1981	208.1	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1203	1205	GTC	273;271;268	G,T;T,A;C,A	271,2;270,1;267,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3316	porB1b	1047	1047	99.14	porB1b.l6.c30.ctg.1	1981	208.1	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1215	1217	TCT	272;272;272	T;C,A;T	272;271,1;272	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3316	porB1b	1047	1047	99.14	porB1b.l6.c30.ctg.1	1981	208.1	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1533	1535	GCA	261;261;262	G;C;A	261;261;262	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3316	porB1b	1047	1047	99.14	porB1b.l6.c30.ctg.1	1981	208.1	1	SNP	p	G120K	1	.	.	358	360	AAG	909	911	AAG	273;273;272	A,G;A;G	272,1;273;272	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3316	porB1b	1047	1047	99.14	porB1b.l6.c30.ctg.1	1981	208.1	1	SNP	p	A121D	1	.	.	361	363	GAC	912	914	GAC	272;275;276	G,T;A,G,C;C	270,2;273,1,1;276	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3316	porB1b	1047	1047	99.14	porB1b.l6.c30.ctg.1	1981	208.1	1	SNP	p	D121N	0	.	.	361	363	GAC	912	914	GAC	272;275;276	G,T;A,G,C;C	270,2;273,1,1;276	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	10954	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5371	254.3	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2222	2224	AAT	287;284;282	A;A;T	287;284;282	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1630	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1431	140.9	1	SNP	p	V57M	1	.	.	169	171	ATG	677	679	ATG	291;291;291	A;T;G,T	291;291;290,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
